Mbemba E - Search Results

1

The procoagulant signature of cancer cells drives fibrin network formation in tumor microenvironment and impacts its quality. Implications in cancer cell migration and the resistance to anticancer agents.

Tran HCM, Mbemba E, Mourot N, Faltas B, Rousseau A, Lefkou E, Sabbah M, van Dreden P, Gerotziafas G. Tran HCM, et al. Among authors: mbemba e. Thromb Res. 2024 Jun;238:172-183. doi: 10.1016/j.thromres.2024.04.015. Epub 2024 Apr 17. Thromb Res. 2024. PMID: 38723522

2

Acceptability and feasibility of tuberculosis and diabetes mellitus bidirectional screening and joint treatment services in Malawi: a cross-sectional study and a policy document review.

Nyirenda JL, Mbemba E, Chirwa M, Mbakaya B, Ngwira B, Wagner D, Toews I, Lange B. Nyirenda JL, et al. Among authors: mbemba e. BMJ Open. 2023 Jan 6;13(1):e062009. doi: 10.1136/bmjopen-2022-062009. BMJ Open. 2023. PMID: 36609325 Free PMC article. Review.

3

Modelization of Blood-Borne Hypercoagulability in Myeloma: A Tissue-Factor-Bearing Microparticle-Driven Process.

Papageorgiou L, Alhaj Hussen K, Thouroude S, Mbemba E, Cost H, Garderet L, Elalamy I, Larsen A, Van Dreden P, Dimopoulos MA, Mohty M, Gerotziafas GT. Papageorgiou L, et al. Among authors: mbemba e. TH Open. 2019 Nov 4;3(4):e340-e347. doi: 10.1055/s-0039-1700885. eCollection 2019 Oct. TH Open. 2019. PMID: 31693008 Free PMC article.

4

Graft Product for Autologous Peripheral Blood Stem Cell Transplantation Enhances Thrombin Generation and Expresses Procoagulant Microparticles and Tissue Factor.

Sidibe F, Spanoudaki A, Vanneaux V, Mbemba E, Larghero J, Van Dreden P, Lotz JP, Elalamy I, Larsen AK, Gerotziafas GT. Sidibe F, et al. Among authors: mbemba e. Clin Appl Thromb Hemost. 2018 May;24(4):684-690. doi: 10.1177/1076029617715116. Epub 2017 Jul 6. Clin Appl Thromb Hemost. 2018. PMID: 28681632 Free PMC article.

5

The Antithrombotic Potential of Tinzaparin and Enoxaparin Upon Thrombin Generation Triggered In Vitro by Human Ovarian Cancer Cells IGROV1.

Sassi M, Chakroun T, Mbemba E, Van Dreden P, Elalamy I, Larsen AK, Gerotziafas GT. Sassi M, et al. Among authors: mbemba e. Clin Appl Thromb Hemost. 2017 Mar;23(2):155-163. doi: 10.1177/1076029616665922. Epub 2016 Sep 24. Clin Appl Thromb Hemost. 2017. PMID: 27609342 Free article.

6

OC-03 - Modelisation of the procoagulant properties of cancer cells and their capacity to alter the antithrombotic efficiency of LMWHs and specific inhibitors of factor Xa.

Gerotziafas GT, Rousseau A, van Dreden P, Mbemba E, Gkalea V, Khaterchi A, Larsen A, Elalamy I. Gerotziafas GT, et al. Among authors: mbemba e. Thromb Res. 2016 Apr;140 Suppl 1:S169. doi: 10.1016/S0049-3848(16)30120-7. Epub 2016 Apr 8. Thromb Res. 2016. PMID: 27161675

7

Cancer cells BXPC3 and MCF7 differentially reverse the inhibition of thrombin generation by apixaban, fondaparinux and enoxaparin.

Rousseau A, Van Dreden P, Mbemba E, Elalamy I, Larsen A, Gerotziafas GT. Rousseau A, et al. Among authors: mbemba e. Thromb Res. 2015 Dec;136(6):1273-9. doi: 10.1016/j.thromres.2015.08.009. Epub 2015 Sep 3. Thromb Res. 2015. PMID: 26489727

8

Characterization of the antithrombotic fingerprint of the branded and copies of the low-molecular-weight enoxaparin using thrombin generation assay.

Gerotziafas GT, Rouseau A, Mbemba E, Khartechi A, Van Dreden P, Walenga J, Fareed J, Elalamy I. Gerotziafas GT, et al. Among authors: mbemba e. Clin Appl Thromb Hemost. 2015 Nov;21(8):697-704. doi: 10.1177/1076029615587355. Epub 2015 May 27. Clin Appl Thromb Hemost. 2015. PMID: 26023170 Free article.

9

Effect of low molecular weight heparins and fondaparinux upon thrombin generation triggered by human pancreatic cancer cells BXPC3.

Gerotziafas GT, Galea V, Mbemba E, Sassi M, Roman MP, Khaterchi A, van Dreden P, Japcowitz M, Lotz JP, Bernaudin JF, Fareed J, Hatmi M, Elalamy I. Gerotziafas GT, et al. Among authors: mbemba e. Curr Vasc Pharmacol. 2014;12(6):893-902. doi: 10.2174/157016111206141210121441. Curr Vasc Pharmacol. 2014. PMID: 22724467

10

Tissue factor over-expression by human pancreatic cancer cells BXPC3 is related to higher prothrombotic potential as compared to breast cancer cells MCF7.

Gerotziafas GT, Galea V, Mbemba E, Khaterchi A, Sassi M, Baccouche H, Prengel C, van Dreden P, Hatmi M, Bernaudin JF, Elalamy I. Gerotziafas GT, et al. Among authors: mbemba e. Thromb Res. 2012 Jun;129(6):779-86. doi: 10.1016/j.thromres.2011.07.049. Epub 2011 Sep 13. Thromb Res. 2012. PMID: 21917301

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26 results

Search Page

Filters